Thyrotropic activity of the ovine corticotropin-releasing factor in the chick embryo.

An injection of several doses of ovine corticotropin-releasing factor (oCRF) was made into an allantoic blood vessel of 18-day-old chick embryos. All doses used (0.5, 1, 2, and 5 micrograms) induce a quick increase of plasma corticosterone concentrations after 15 and 30 min and 1 and 2 hr and this in a dose-dependent manner with the high doses having a prolonged effect lasting up to 2 hr. An increase in plasma levels of thyroxine (T4) and triiodothyronine (T3) was observed after 1 and 2 hr. After the oCRF injection, no stimulation of the hepatic 5'-monodeiodination activity was observed and there was no increase, but even a small decrease in the T3 to T4 ratio could be calculated. It was therefore concluded that oCRF in the chick embryo has a thyrotropic effect presumably by stimulating the release of thyrotropin from the pituitary.

Effect of the sex-linked dwarf gene on thyrotrophic and somatotrophic axes in the chick embryo.

Plasma concentrations of thyroxine (T4), triiodothyronine (T3), reversed triiodothyronine (rT3), and insulin-like growth factors I and II (IGF-I, IGF-II) together with peripheral 5'-monodeiodination activity were measured in both normal and sex-linked dwarf embryos between day 14 of incubation and day 1 posthatch. Plasma T4 levels increased gradually during embryonic development while T3 concentrations remained low until day 20, when a sharp increase was observed. rT3 levels also increased from day 14 and dropped on day 20 when T3 levels started to increase. 5'-monodeiodination activity was high on day 14 of incubation, decreased thereafter, and showed an increase at the time of air sac penetration together with increased T3 levels. At this stage, differences between normal and dwarf embryos were observed; the latter had lower nonsignificant 5'-Monodeiodination activity and lower (P less than 0.01) plasma T3 levels. Plasma IGF-II levels were high during the whole embryonic period studied. Dwarf embryos had lower (P less than 0.05) IGF-II levels at the time of hatching. IGF-I levels were high on days 14 and 16, declined afterwards, and started to increase again around hatching. With the exception of T3 and IGF-II levels, introduction of the dwarf gene did not cause major changes in the hormonal parameters studied. This may explain the identical body weight at hatching.

Thyroxine and triiodothyronine in plasma and thyroids of the neotenic and metamorphosed axolotl Ambystoma mexicanum: influence of TRH injections.

Circulating levels of T3 and T4, as well as T3 and T4 content of the thyroid glands were measured by radioimmunoassay in the neotenic and metamorphosed axolotl Ambystoma mexicanum. In the two experiments which were performed plasma T4 concentrations were more elevated in metamorphosed axolotls, especially in the first experiment (2.12 +/- 0.40 ng/ml vs. 369 +/- 30 pg/ml). T3 plasma values which were only estimated in the second experiment were about five times higher in metamorphosed animals (63.2 +/- 7.4 pg/ml vs. 12.5 +/- 0.8 pg/ml). Also the thyroid hormone content of the glands was higher after metamorphosis. Nevertheless the neotenic gland still contained considerable amounts of T3 (14.7 +/- 1.8 ng and 48.3 +/- 4.8 ng/thyroid, respectively, in the first and second experiment) and T4 (530 +/- 61 ng; 2173 +/- 291 ng/thyroid). Because of the higher T3/T4 ratio found in the plasma compared to the thyroid gland, it was suggested that circulating T3 may be derived partly from peripheral T4 conversion, mainly after metamorphosis. An intravenous injection of 10 micrograms synthetic TRH was able to induce a very significant increase of the plasma T4 concentration (which was maintained during 24 hr) in the metamorphosed axolotls of the first experiment, however, not in those of the second experiment nor in the neotenic animals. Following an injection of 10 mU bovine TSH (first experiment) circulating levels of T4 were raised in both groups. The opposing TRH results could be related with the different control levels of T4 in the two experiments. However, the results indicate that TRH is capable of functioning as a possible thyrotropin-releasing factor in the metamorphosed axolotl.

Thyrotropic and peripheral activities of thyrotrophin and thyrotrophin-releasing hormone in the chick embryo and adult chicken.

The influence of an intravenous injection of thyrotrophin-releasing hormone (TRH) and bovine thyrotrophin (TSH) on circulating levels of thyroid hormones and the liver 5'-monodeiodination (5'-D) activity is studied in the chick embryo and the adult chicken. In the 18-day-old chick embryo, an injection of 1 microgram TRH and 0.01 I.U. TSH increase plasma concentrations of triiodothyronine (T3) and of thyroxine (T4). TRH, however, preferentially raises plasma levels of T3, resulting in an increased T3 to T4 ratio, whereas TSH preferentially increases T4, resulting in a decreased T3 to T4 ratio. The 5'-D-activity is also stimulated following TRH but not following TSH administration. The increase of reverse T3 (rT3) is much more pronounced following the administration of TSH. In adult chicken an injection of up to 20 micrograms of TRH never increased plasma concentrations of T4, but increases T3 at every dose used together with 5'-D at the 20 micrograms dose. TSH on the other hand never increased T3 or 5'-D, but elevates T4 consistently. It is concluded that TSH is mainly thyrotropic in the chick embryo or adult chicken whereas TRH is responsible for the peripheral conversion of T4 into T3 by stimulating the 5'-D-activity. The involvement of a TRH induced GH release in this peripheral activity is discussed.